Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Data Sheet 1_Development and validation of the FAAP model for prognostic stratification in HCC patients treated with TACE, sintilimab plus bevacizumab: a multicenter study.docx

Introduction<p>Although the transcatheter arterial chemoembolization (TACE) combined with sintilimab and bevacizumab improves outcomes in unresectable HCC (uHCC), predictive tools are lacking. This study developed and validated a prognostic model for triple therapy efficacy.</p>Methods&l...

Повний опис

Збережено в:
Бібліографічні деталі
Автор: Liying Ren (11143129) (author)
Інші автори: Dongbo Chen (10430738) (author), Xue Zhang (166886) (author), Shaoping She (22678979) (author), Ran Fei (93650) (author), Xu Cong (159269) (author), Shaowei Mu (22678982) (author), Yuchen Zhou (1601536) (author), Jie Gao (10266) (author), Weijia Liao (492662) (author), Hongsong Chen (159274) (author)
Опубліковано: 2025
Предмети:
Genetic Immunology
hepatocellular carcinoma
immunotherapy
transcatheter arterial chemoembolization
prognostic model
FAAP score
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Будьте першим, хто залишить коментар!
Спочатку зайдіть до системи

Схожі ресурси